A high proportion of CD8+ T cells in the final TIL product,25 in vitro cytotoxicity against autologous tumor cells and in vivo persistence of TIL post transfer have been associated with improved clinical response in metastatic melanoma. Here, CD8A is linked to metastatic melanoma.